Matinas BioPharma Holdings, Inc. announced the appointment of Thomas Hoover to the newly created position of Chief Business Officer. Mr. Hoovers role will include business and corporate development, strategic planning, licensing, and alliance management. Mr. Hoover has nearly 20 years of strategic biopharmaceutical experience in business and corporate development roles, as well as new product planning across a wide range of therapeutic categories including CNS, oncology, cell therapy, autoimmune diseases, endocrinology and CV/metabolic. Thomas was most recently Chief Business Officer and Chief Commercial Officer at Millendo Therapeutics, a publicly traded biotechnology company, where he led corporate development efforts and defined and executed commercial strategy.